219 related articles for article (PubMed ID: 16045866)
1. Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers.
Gonzalo Garijo MA; Pérez Calderón R; de Argila Fernández-Durán D; Rangel Mayoral JF
Allergol Immunopathol (Madr); 2005; 33(4):238-40. PubMed ID: 16045866
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature.
Knowles S; Gupta AK; Shear NH
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):201-6. PubMed ID: 9486675
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous adverse reactions associated with calcium channel blockers.
Stern R; Khalsa JH
Arch Intern Med; 1989 Apr; 149(4):829-32. PubMed ID: 2523214
[TBL] [Abstract][Full Text] [Related]
4. Contact dermatitis caused by diltiazem cream and cross-reactivity with other calcium channel blockers.
Forkel S; Baltzer AB; Geier J; Buhl T
Contact Dermatitis; 2018 Oct; 79(4):244-246. PubMed ID: 29851108
[No Abstract] [Full Text] [Related]
5. Exfoliative dermatitis associated with diltiazem.
Odeh M
J Toxicol Clin Toxicol; 1997; 35(1):101-4. PubMed ID: 9022661
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous reactions induced by calcium channel blocker: high frequency of psoriasiform eruptions.
Kitamura K; Kanasashi M; Suga C; Saito S; Yoshida S; Ikezawa Z
J Dermatol; 1993 May; 20(5):279-86. PubMed ID: 8340532
[TBL] [Abstract][Full Text] [Related]
7. Acute generalized exanthematous pustulosis induced by diltiazem: value of patch testing.
Jan V; Machet L; Gironet N; Martin L; Machet MC; Lorette G; Vaillant L
Dermatology; 1998; 197(3):274-5. PubMed ID: 9867362
[No Abstract] [Full Text] [Related]
8. Diltiazem-induced acute generalised exanthematous pustulosis.
Wakelin SH; James MP
Clin Exp Dermatol; 1995 Jul; 20(4):341-4. PubMed ID: 8548996
[TBL] [Abstract][Full Text] [Related]
9. Facial hyperpigmentation caused by diltiazem hydrochloride.
Desai N; Alexis AF; DeLeo VA
Cutis; 2010 Aug; 86(2):82-4. PubMed ID: 20919601
[TBL] [Abstract][Full Text] [Related]
10. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
11. Letter: Photodistributed reticulated hyperpigmentation related to diltiazem.
Jaka A; López-Pestaña A; Tuneu A; Lobo C; López-Núñez M; Ormaechea N
Dermatol Online J; 2011 Jul; 17(7):14. PubMed ID: 21810399
[TBL] [Abstract][Full Text] [Related]
12. Patch tests for diagnosis of delayed hypersensitivity to cephalosporins.
Gonzalo-Garijo MA; Rodríguez-Nevado I; de Argila D
Allergol Immunopathol (Madr); 2006; 34(1):39-41. PubMed ID: 16540071
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous adverse reactions to calcium channel blockers.
Tuchinda P; Kulthanan K; Khankham S; Jongjarearnprasert K; Dhana N
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):246-50. PubMed ID: 25268343
[TBL] [Abstract][Full Text] [Related]
14. Systemic allergic dermatitis caused by diltiazem.
Opstrup MS; Guldager S; Zachariae C; Thyssen JP
Contact Dermatitis; 2017 Jun; 76(6):364-365. PubMed ID: 28497625
[No Abstract] [Full Text] [Related]
15. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
16. Vesicular Contact Reaction May Progress into Erythema Multiforme.
Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
[TBL] [Abstract][Full Text] [Related]
17. Gingival hyperplasia: a side effect of nifedipine and diltiazem.
Fattore L; Stablein M; Bredfeldt G; Semla T; Moran M; Doherty-Greenberg JM
Spec Care Dentist; 1991; 11(3):107-9. PubMed ID: 1887359
[TBL] [Abstract][Full Text] [Related]
18. Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross reactions between calcium channel blockers.
Cholez C; Trechot P; Schmutz JL; Faure G; Bene MC; Barbaud A
Allergy; 2003 Nov; 58(11):1207-9. PubMed ID: 14616146
[No Abstract] [Full Text] [Related]
19. Update on calcium-channel blocking agents.
Talbert RL; Bussey HI
Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem-induced photodistributed hyperpigmentation.
Boyer M; Katta R; Markus R
Dermatol Online J; 2003 Dec; 9(5):10. PubMed ID: 14996383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
